Daunorubicin Hydrochloride is an anthracycline antibiotic that intercalates into DNA and inhibits topoisomerase II, used in induction chemotherapy for acute leukaemias. Simson Pharma's Daunorubicin Hydrochloride reference standard and impurities support the precise potency and degradation-product testing this high-potency oncology injectable requires.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Daunorubicin Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.